###begin article-title 0
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax Lethal Toxin Impairs IL-8 Expression in Epithelial Cells through Inhibition of Histone H3 Modification
###end article-title 0
###begin p 1
Conceived and designed the experiments: BR EB CM PLG LT. Performed the experiments: BR EB FB YZW DL VB ER. Analyzed the data: BR EB FB YZW DL VB CM PLG LT. Contributed reagents/materials/analysis tools: ER PLG. Wrote the paper: BR CM PLG LT.
###end p 1
###begin p 2
###xml 52 70 52 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 297 309 297 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 537 549 537 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 677 685 677 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1364 1376 1348 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1628 1640 1608 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 52 70 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 97 104 <span type="species:ncbi:1392">anthrax</span>
###xml 297 309 <span type="species:ncbi:1392">B. anthracis</span>
###xml 537 549 <span type="species:ncbi:1392">B. anthracis</span>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
###xml 702 707 <span type="species:ncbi:9606">human</span>
###xml 1364 1376 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1628 1640 <span type="species:ncbi:1392">B. anthracis</span>
Lethal toxin (LT) is a critical virulence factor of Bacillus anthracis, the etiological agent of anthrax, whose pulmonary form is fatal in the absence of treatment. Inflammatory response is a key process of host defense against invading pathogens. We report here that intranasal instillation of a B. anthracis strain bearing inactive LT stimulates cytokine production and polymorphonuclear (PMN) neutrophils recruitment in lungs. These responses are repressed by a prior instillation of an LT preparation. In contrast, instillation of a B. anthracis strain expressing active LT represses lung inflammation. The inhibitory effects of LT on cytokine production are also observed in vitro using mouse and human pulmonary epithelial cells. These effects are associated with an alteration of ERK and p38-MAPK phosphorylation, but not JNK phosphorylation. We demonstrate that although NF-kappaB is essential for IL-8 expression, LT downregulates this expression without interfering with NF-kappaB activation in epithelial cells. Histone modifications are known to induce chromatin remodelling, thereby enhancing NF-kappaB binding on promoters of a subset of genes involved in immune response. We show that LT selectively prevents histone H3 phosphorylation at Ser 10 and recruitment of the p65 subunit of NF-kappaB at the IL-8 and KC promoters. Our results suggest that B. anthracis represses the immune response, in part by altering chromatin accessibility of IL-8 promoter to NF-kappaB in epithelial cells. This epigenetic reprogramming, in addition to previously reported effects of LT, may represent an efficient strategy used by B. anthracis for invading the host.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 358 370 358 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 407 419 407 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 594 606 594 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 849 861 849 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1142 1154 1142 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1241 1253 1241 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 0 18 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 45 52 <span type="species:ncbi:1392">anthrax</span>
###xml 358 370 <span type="species:ncbi:1392">B. anthracis</span>
###xml 407 419 <span type="species:ncbi:1392">B. anthracis</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 479 486 <span type="species:ncbi:1392">anthrax</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
###xml 594 606 <span type="species:ncbi:1392">B. anthracis</span>
###xml 849 861 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1142 1154 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1241 1253 <span type="species:ncbi:1392">B. anthracis</span>
Bacillus anthracis, the etiological agent of anthrax, can infect mammals either accidentally or as a potential consequence of a terrorism threat. Pulmonary infection is a life-threatening form of the disease, causing a near 100% mortality rate in the absence of appropriate therapy. Thus, it is important to understand the mechanisms of host defense against B. anthracis. We examined the effects of various B. anthracis strains on lung inflammation in a mouse model of pulmonary anthrax and on human lung epithelial cells, the first barrier of lung against invading pathogens. We showed that a B. anthracis strain expressing lethal toxin inhibits inflammation. In contrast, a strain in which this toxin has been inactivated induces lung inflammation. We next examined the mechanisms involved in the inhibitory effect of lethal toxin. We showed that B. anthracis injects lethal toxin into epithelial cells, blocks the molecules associated on the chromosome, and thus represses production of mediators involved in inflammation. As the latter is a key process in host defense, its alteration by lethal toxin predisposes the host to infection by B. anthracis. This effect on the chromosomal machinery may represent an efficient strategy used by B. anthracis for invading the host.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 23 35 23 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Mock1">[1]</xref>
###xml 398 401 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Lincoln1">[2]</xref>
###xml 402 405 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Ross1">[3]</xref>
###xml 677 680 677 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Turnbull1">[4]</xref>
###xml 743 755 743 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 23 35 <span type="species:ncbi:1392">B. anthracis</span>
###xml 60 67 <span type="species:ncbi:1392">anthrax</span>
###xml 203 210 <span type="species:ncbi:1392">anthrax</span>
###xml 589 596 <span type="species:ncbi:1392">anthrax</span>
###xml 743 755 <span type="species:ncbi:1392">B. anthracis</span>
###xml 809 816 <span type="species:ncbi:1392">anthrax</span>
Pulmonary infection by B. anthracis, the etiologic agent of anthrax disease [1], has been shown to be the most life-threatening form of the disease as compared to gastrointestinal and cutaneous forms of anthrax. Whatever the infection route used by this bacterium, spores are taken up by macrophages and/or dendritic cells, and subsequently migrate in the draining lymph nodes where they germinate [2],[3]. Germination leads to bacterial multiplication and dissemination through the whole organism. Despite a therapeutic intervention, all forms of infection may progress to fatal systemic anthrax, which is characterized by shock-like symptoms, sepsis, and respiratory failure [4]. Therefore, investigation of the immune response triggered by B. anthracis may help to better understand the pathophysiology of anthrax and to develop efficient therapeutic approaches for the treatment of this disease.
###end p 6
###begin p 7
###xml 397 400 397 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baggiolini1">[5]</xref>
###xml 688 691 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Hoffmann1">[6]</xref>
###xml 880 883 868 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Hoffmann1">[6]</xref>
###xml 1214 1217 1202 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Strahl1">[7]</xref>
###xml 1218 1221 1206 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Thomson1">[8]</xref>
###xml 1533 1536 1521 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Clayton1">[9]</xref>
###xml 1537 1541 1525 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Volmat1">[10]</xref>
###xml 276 281 <span type="species:ncbi:9606">human</span>
The innate immune response, including the inflammatory reaction that is the first line of host defense against invading pathogens, is characterized by upregulation of various inflammatory genes due to the activation of transcription factors. IL-8 (Interleukine-8, CXCL8) is a human chemokine that induces the recruitment of polymorphonuclear (PMN) neutrophils from the blood to the injured tissue [5]. This allows PMN to eradicate the invading pathogen within the site of infection. In healthy tissues, IL-8 is barely detectable, but is rapidly induced by nuclear factor kappaB (NF-kappaB) and activator protein 1 (AP-1)-dependent inflammatory stimuli such as TNFalpha, bacteria or virus [6]. Recently, significant advances in the understanding of signaling pathways, which regulate IL-8 transcription as well as mRNA stabilization in response to external stimuli, have been made [6]. It is now clearly established that induction of inflammatory genes is associated with local changes in histone modification that plays a major role in epigenetic regulation of gene expression. The core histones including H2A, H2B, H3 and H4 are the basic components of the nucleosomes that organize the cellular DNA in chromatin [7],[8]. Covalent modifications of the histones play a major role in gene regulation by affecting chromatin compaction and thereby DNA accessibility. These modifications can result in either transcriptional repression (like for H3me3K9 and H3me1K27) or activation (H3me3K4, H3pS10 and acetylation at various positions) [9],[10].
###end p 7
###begin p 8
###xml 30 42 30 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 253 256 253 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Lincoln1">[2]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baldari1">[11]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Fukao1">[12]</xref>
###xml 305 317 305 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baldari1">[11]</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Raymond1">[13]</xref>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 453 465 453 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Duesbery1">[14]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Vitale1">[15]</xref>
###xml 30 42 <span type="species:ncbi:1392">B. anthracis</span>
###xml 51 58 <span type="species:ncbi:1392">anthrax</span>
###xml 305 317 <span type="species:ncbi:1392">B. anthracis</span>
###xml 453 465 <span type="species:ncbi:1392">B. anthracis</span>
###xml 731 738 <span type="species:ncbi:1392">anthrax</span>
The exact mechanisms by which B. anthracis induces anthrax disease are not fully understood; however, it is clearly established that this bacterium spreads rapidly into the host at the early stages of infection with low or no detectable immune response [2],[11],[12]. This is likely due to the ability of B. anthracis to subvert the host immune response [11]-[13]via, at least in part, the action of tow major toxins, edema toxin and lethal toxin (LT). B. anthracis secretes a transporter called protective antigen (PA) which acts in pair with lethal factor (LF) leading to the formation of lethal toxin (LT). LT cleaves MAPKK thereby interfering with MAPK cascade [14],[15] a process known to play a major role in pathogenesis of anthrax. However, the molecular mechanisms that may link MAPK inhibition by LT and modulation of target gene expression remained unclear.
###end p 8
###begin p 9
###xml 579 591 571 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 88 95 <span type="species:ncbi:1392">anthrax</span>
###xml 579 591 <span type="species:ncbi:1392">B. anthracis</span>
We report here that LT impaired the inflammatory response in a mouse model of pulmonary anthrax. Remarkably, LT repressed IL-8 expression without interfering with NF-kappaB activation, an essential transcription factor for IL-8 expression. Investigation of the molecular mechanisms involved in this inhibition revealed that LT blocked histone (H3) phosphorylation at serine 10, a modification normally induced by activation of the MAPK pathway and that is also involved in chromatin accessibility for NF-kappaB. This epigenetic reprogramming is probably a key mechanism by which B. anthracis circumvents the immune response during the earlier stage of infection.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 11 23 11 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 11 23 <span type="species:ncbi:1392">B. anthracis</span>
LT impairs B. anthracis-induced lung inflammatory response
###end title 11
###begin p 12
###xml 26 38 26 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 580 589 580 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g001">Figure 1A</xref>
###xml 612 621 612 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g001">Figure 1B</xref>
###xml 826 835 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g001">Figure 1A</xref>
###xml 858 867 858 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g001">Figure 1B</xref>
###xml 991 1000 991 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g001">Figure 1C</xref>
###xml 1023 1032 1023 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g001">Figure 1D</xref>
###xml 26 38 <span type="species:ncbi:1392">B. anthracis</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 90 97 <span type="species:ncbi:1392">anthrax</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
We examined the effect of B. anthracis on lung inflammation in a mouse model of pulmonary anthrax and the contribution of LT to this effect. All strains used in this study were in bacilli form. The degree of inflammatory reaction was assessed by measuring the recruitment of polymorphonuclear (PMN) leukocyte, and the levels of proinflammatory cytokines interleukin-6 (IL-6) and KC (mouse functional orthologue of human IL-8) in broncho-alveolar lavage fluids (BALFs). Intranasal instillation of the RPLC2 strain (producing inactive LT) induced an increase of IL-6 and KC levels (Figure 1A) and PMN recruitment (Figure 1B), in contrast to the RP9 strain (producing active LT) which had no effect. Intratracheal instillation of LT to mice before bacterial administration impaired RPLC2-induced increases of IL-6 and KC levels (Figure 1A) and PMN recruitment (Figure 1B). Intranasal instillation of LPS (instead of bacteria) induced an increase in concentrations of MIP-2, KC and IL-6 levels (Figure 1C) and PMN recruitment (Figure 1D). All these responses were abrogated by intratracheal instillation of LT before LPS.
###end p 12
###begin title 13
LT impairs pulmonary inflammatory response.
###end title 13
###begin p 14
###xml 152 153 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 6 10 <span type="species:ncbi:10090">Mice</span>
###xml 299 303 <span type="species:ncbi:10090">Mice</span>
(A,B) Mice received intratracheal instillation of LT (550 microg/kg) or saline 1 h before intranasal instillation of germinated RP9 or RPLC2 bacilli (107 cfu). Sixteen hours later, BALs were performed, then KC and IL-6 concentrations (A), and the numbers of PMN neutrophils (B) were measured. (C,D) Mice received intratracheal instillation of LT (550 microg/kg) or saline 1 h before intranasal instillation of LPS (330 microg/kg). Sixteen hours later, BALs were performed, and the concentrations of MIP-2, KC, and IL-6 (C) and numbers of PMN neutrophils (D) were determined.
###end p 14
###begin title 15
LT modulates cytokine expression by lung epithelial cells
###end title 15
###begin p 16
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 208 217 208 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g002">Figure 2F</xref>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
These findings led us to examine the effect of LT on the in vitro secretion of cytokines by primary cells isolated from mouse lungs. LT blocked LPS-induced KC and IL-6 secretions by primary epithelial cells (Figure 2F) and MIP-2, KC and IL-6 secretions by alveolar macrophage (AMs) (data not shown).
###end p 16
###begin title 17
LT modulates cytokine expression by epithelial cells.
###end title 17
###begin p 18
###xml 43 55 43 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 43 55 <span type="species:ncbi:1392">B. anthracis</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
(A,B) Beas-2B cells were infected with the B. anthracis strains RP9 and RPLC2 at an MOI of 20:1 for 3 h in the absence of antibiotics. Cells were then washed and incubated in a medium supplemented with antibiotics in the absence (A) or presence (B) of TNFalpha. After 24 h incubation, supernatants were collected and IL-8 concentrations were measured. (C,D) Beas-2B cells were pretreated with LT (PA+LF) for 1 h before stimulation with TNFalpha (10 ng/ml). A fixed concentration of PA (1 microg/ml) and increasing concentrations of LF were used. After 24 h incubation, IL-8 mRNA expression (C) and IL-8 secretion (D) were measured. (E) Beas-2B cells were pretreated with LT (1 microg/ml) for 1 h before stimulation with TNFalpha (10 ng/ml), and IL-6 concentrations were measured after 24 h incubation. (F) Epithelial cells were isolated from lungs of naive mice and pretreated with LT (1 microg/ml) for 1 h before incubation with LPS (1 microg/ml). KC and IL-6 secretions were measured after 24 h stimulation.
###end p 18
###begin p 19
###xml 207 216 207 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g002">Figure 2A</xref>
###xml 317 326 313 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g002">Figure 2B</xref>
###xml 379 388 371 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g002">Figure 2C</xref>
###xml 397 406 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g002">Figure 2D</xref>
###xml 418 427 410 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g002">Figure 2E</xref>
###xml 83 88 <span type="species:ncbi:9606">human</span>
We next investigated in more details the effects of LT on cytokine production in a human epithelial cell line Beas-2B. The RPLC2 strain induced IL-8 secretion by Beas-2B cells in contrast to the RP9 strain (Figure 2A). The RP9 strain inhibited TNFalpha-induced IL-8 secretion, whereas the RPLC2 strain had no effect (Figure 2B). LT blocked TNFalpha-induced IL-8 mRNA expression (Figure 2C), IL-8 (Figure 2D) and IL-6 (Figure 2E) secretions. Inhibition of IL-8 secretion by LT was also observed when Beas-2B cells were stimulated by IL-1beta or LPS instead of TNFalpha (data not shown).
###end p 19
###begin title 20
Inhibition of IL-8 expression by LT is not due to an alteration of NF-kappaB activation/translocation
###end title 20
###begin p 21
###xml 90 93 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Thomson1">[8]</xref>
###xml 499 508 471 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g003">Figure 3A</xref>
###xml 611 620 575 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g003">Figure 3B</xref>
As NF-kappaB is a key transcription factor of inflammatory gene expression including IL-8 [8], we examined its implication in IL-8 expression in our cell system. We analyzed IL-8-promoter activation in Beas-2B cells transfected with the (-133 pb) IL-8-promoter or an [DeltaNF-kappaB] IL-8 promoter in which the responsive elements of NF-kappaB were mutated. TNFalpha induced the activation of the (-133 pb) IL-8-promoter but failed to stimulate the activation of the [DeltaNF-kappaB] IL-8 promoter (Figure 3A). Preincubation of cells with BAY, an NF-kappaB inhibitor, abrogated TNFalpha-induced IL-8 secretion (Figure 3B). These findings indicated that NF-kappaB is essential for IL-8 expression in Beas-2B cells. The use of the [DeltaAP-1] and [DeltaNF-IL6] IL-8 promoter showed that AP-1 and NF-IL6 are only marginally involved in the induction of the IL-8 expression by TNFalpha (data not shown).
###end p 21
###begin title 22
LT inhibits IL-8 expression through a process independent of NF-kappaB activation.
###end title 22
###begin p 23
(A) Beas-2B cells were transfected with IL-8 promoter (-133 pb) or [DeltaNF-kappaB] IL-8 promoter reporter plasmids before stimulation with TNFalpha (10 ng/ml). Luciferase activity was measured after 24 h stimulation. (B) Cells were pretreated with BAY (10 microM) for 1 h and stimulated with TNFalpha (10 ng/ml). IL-8 concentrations were measured in supernatants after 24 h stimulation. (C) Cells were pretreated for 1 h with LT (1 microg/ml), SB203580, or PD98059 and incubated with TNFalpha (10 ng/ml). NF-kappaB luciferase activity was analysed after 24 h stimulation. (D) Cells were pretreated with LT (1 microg/ml), SB203580 (10 microM), or PD98059 (10 microM) and then stimulated with TNFalpha (10 ng/ml) for an additional 2 h. NF-kappaB translocation was analysed by EMSA.
###end p 23
###begin p 24
###xml 294 310 282 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g003">Figure 3C and 3D</xref>
These findings led us to examine whether inhibition of IL-8 expression by LT is due to an alteration of NF-kappaB activation. Our results showed that neither LT nor MAPK inhibitors inhibited TNFalpha induced NF-kappaB activation or translocation. MAPK inhibitors even enhanced this activation (Figure 3C and 3D).
###end p 24
###begin title 25
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
LT inhibits IL-8 expression via a MAPK-dependent pathway
###end title 25
###begin p 26
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Thomson1">[8]</xref>
###xml 319 328 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g004">Figure 4B</xref>
###xml 395 404 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g004">Figure 4C</xref>
###xml 475 479 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Duesbery1">[14]</xref>
###xml 480 484 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Vitale1">[15]</xref>
###xml 592 601 584 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g004">Figure 4A</xref>
###xml 774 783 762 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g004">Figure 4D</xref>
###xml 1196 1205 1180 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g004">Figure 4E</xref>
MAPK cascade is known to modulate IL-8 expression in various cell systems [8]. This was confirmed in the present study using SB202190 and PD98059, specific inhibitors of p38-MAPK and ERK, respectively. Indeed, pre-treatment of Beas-2B cells with these compounds, significantly reduced TNFalpha-induced IL-8 expression (Figure 4B). We also showed that LT cleaves MEK1, MEK2, MEK3 in these cells (Figure 4C), a finding in agreement with the know ability of LT to cleave MAPKKs [14],[15]. LT inhibited TNFalpha-induced ERK and p38-MAPK phosphorylation, but had no effect on JNK phosphorylation (Figure 4A). Studies on Beas-2B cells transfected with the IL-8 promoter reporter plasmid showed that LT and MAPK inhibitors had no effect on TNFalpha-induced IL-8 promoter activity (Figure 4D), which contrasted with the ability of these compounds to inhibit the expression of endogenous IL-8. We next examined the effect of LT on the activation of mitogen and stress-activated kinases (MSK), located down-stream MAPKK pathways, and involved in histone phosphorylation. Incubation of Beas-2B cells with TNFalpha increased the level of MSK2 phosphorylation which was reduced by pre-treating cells with LT (Figure 4E). No detectable expression of MSK1 or phospho-MSK1 was observed in these cells (data not shown).
###end p 26
###begin title 27
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
LT inhibits IL-8 expression via a MAPK-dependent pathway in Beas-2B cells.
###end title 27
###begin p 28
(A) Beas-2B cells were incubated for 1 h with LT (1 microg/ml) and stimulated with TNFalpha (10 ng/ml) for an additional 2 h. Western blot analyses were performed using antibodies directed against ERK, phospho-ERK (ERKpT202-Y204), p38, phospho-p38 (p38pT180-Y182), JNK, and phospho-JNK (JNKpT183-Y185) and were normalized with ss-actin antibody. (B) Cells were pretreated with SB203580 (10 microM) or PD98059 (10 microM) for 1 h before incubation with TNFalpha (10 ng/ml). IL-8 concentrations were measured in supernatants after 24 h stimulation. (C) Cells were incubated for 1 h with LT (1 microg/ml) and stimulated by TNFalpha (10 ng/ml) for an additional 2 h. Western blot analyses were performed using antibodies directed against MEK-1, MEK-2, and MEK-3 and were normalized with ss-actin antibody. (D) Cells were transfected with an IL-8 promoter reporter plasmid, and then incubated for 1 h with LT (1 microg/ml), SB203580 (10 microM), or PD98059 (10 microM) before addition of TNFalpha (10 ng/ml). Luciferase activity was then measured after 24 h stimulation. (E) Cells were incubated for 1 h with LT (1 microg/ml) and stimulated by TNFalpha (10 ng/ml) for an additional 45 min. Western blot analyses were performed using antibodies directed against MSK-2 and phospho-MSK-2 and normalized with ss-actin antibody.
###end p 28
###begin title 29
LT impairs histone H3S10 phosphorylation and IL-8 and KC promoter accessibility
###end title 29
###begin p 30
###xml 309 312 301 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baggiolini1">[5]</xref>
###xml 313 316 305 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Thomson1">[8]</xref>
###xml 460 476 448 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g005">Figure 5A and 5B</xref>
###xml 1033 1042 1005 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g006">Figure 6A</xref>
###xml 1391 1400 1355 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g006">Figure 6B</xref>
###xml 1713 1722 1677 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g006">Figure 6B</xref>
The results above suggested that LT inhibited IL-8 expression, at a site probably located down-stream of NF-kappaB activation/translocation and depending on MAPK cascade. This led us to examine the effect of LT on the phosphorylation of H3, known to promote the accessibility of NF-kappaB to target promoters [5]-[8]. Western blot and immunofluorescence analyses showed that LT suppressed TNFalpha-induced H3 phosphorylation at Ser10 and acetylation at Lys14 (Figure 5A and 5B) in Beas-2B cells, suggesting that LT can impair the chromatin accessibility of NF-kappaB at the IL-8 promoter. We stimulated Beas-2B by TNFalpha with or without LT and then carried out chromatin immunoprecipitation (ChIP) assays using an antibody against p65 subunit of NF-kappaB, RNAPII antibodies or using an irrelevant immunoglobulin G (IgG) of the same isotype as a control. ChIP analyses showed that LT suppressed TNFalpha-induced p65 and RNAPII recruitment to the IL-8 promoter while no effect was observed in the recruitment at the GAPDH promoter (Figure 6A). In addition, the results showed that TNFalpha induced phosphorylation at Ser10 and acetylation at Lys14 of histone H3 on the IL-8 promoter whereas the other modifications on H3 were not significantly regulated. LT abrogated TNFalpha-induced presence of di-modified histone H3 phosphorylated at Ser10 and acetylated at Lys14 at the IL-8 promoter (Figure 6B). Acetylation at Lys9 and tri-methylation at Lys4 (known to reflect positive modulation of transcription) were not modified on the IL-8 promoter in our experimental conditions. Tri-methylation at Lys9, which generally correlates with inhibition of transcription, occurred in parallel to tri-methylation at Lys4 (Figure 6B).
###end p 30
###begin title 31
LT impairs H3 phosphorylation.
###end title 31
###begin p 32
Beas-2B cells were incubated for 1 h with LT (1 microg/ml) and stimulated with TNFalpha (10 ng/ml) for an additional 2 h. Western blot analyses were performed using H3, H3pS10, and H3pS10-AcK14 antibodies and were normalized with a beta-actin antibody (A). Immunofluorescence analyses were performed using an H3pS10 antibody and DAPI (B).
###end p 32
###begin title 33
LT impairs IL-8 promoter accessibility.
###end title 33
###begin p 34
###xml 320 326 <span type="species:ncbi:9986">rabbit</span>
Beas-2B cells were incubated for 1 h with LT (1 microg/ml) and stimulated with TNFalpha (10 ng/ml) for additional 45 min. Cells were fixed with formaldehyde and then chromatin sonicated. The relative recruitment of NF-kappaB-p65 (p65) and the RNAPII (RNA Polymerase II) ChIP were expressed relative to the non-immun IgG rabbit used as a negative control (A). The H2B and the H3 histone tail modifications ChIP were reported to the H3 ChIP and expressed in percentages (B). Each value was corrected for the recruitment of each antibody on the CD44 exon 2 region used as an unregulated control gene by the TNFalpha and the LT. Note that the H2B signal relative to H3 is constant upon treatment and the promoters. It was three times more important than H3, probably because of the relative efficiency of antibodies.
###end p 34
###begin p 35
###xml 295 303 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000359-g007">Figure 7</xref>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
We next performed ChIP analyses on a mouse epithelial cell line MLE-15 to examine the effect of LT on the KC promoter. We verified that LT inhibited TNFalpha-induced KC expression in these cells (data not shown). We observed almost similar regulations of histone modifications in this promoter (Figure 7). The weaker effects on KC versus IL-8 of the TNFalpha treatment on the H3pS10 and AcK14 modifications could be explained partially by the fact that the KC promoter appears to contain more H3me3K4 than the IL-8 promoter (160% of H3 versus 40% of H3, respectively), suggesting that the KC promoter chromatin could be in a more opened configuration than the IL-8 one.
###end p 35
###begin title 36
LT impairs KC promoter accessibility.
###end title 36
###begin p 37
###xml 322 328 <span type="species:ncbi:9986">rabbit</span>
MLE-15 cells were incubated for 1 h with LT (1 microg/ml) and stimulated with TNFalpha (10 ng/ml) for an additional 45 min. Cells were fixed with formaldehyde and then chromatin sonicated. The relative recruitment of NF-kappaB-p65 (p65) and the RNAPII (RNA Polymerase II) ChIP were expressed relative to the non-immun IgG rabbit used as a negative control (A). The H2B and the H3 histone tail modifications ChIP were reported to the H3 ChIP and expressed in percentages (B). Each value was corrected for the recruitment of each antibody on the CD44 exon 2 region used as an unregulated control gene by TNFalpha and LT. Note that the H2B signal relative to H3 is constant upon treatment and the promoters. It was two times more important than H3, probably because of the relative efficiency of antibodies.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 116 128 116 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 128 131 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Mock1">[1]</xref>
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Ross1">[3]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Lincoln1">[2]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baldari1">[11]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Fukao1">[12]</xref>
###xml 329 341 329 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baldari1">[11]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Fukao1">[12]</xref>
###xml 473 485 473 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 661 673 661 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 929 941 929 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Pickering1">[16]</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Tournier1">[18]</xref>
###xml 1089 1101 1089 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1202 1206 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Raymond1">[13]</xref>
###xml 10 17 <span type="species:ncbi:1392">anthrax</span>
###xml 53 59 <span type="species:ncbi:9606">humans</span>
###xml 116 128 <span type="species:ncbi:1392">B. anthracis</span>
###xml 329 341 <span type="species:ncbi:1392">B. anthracis</span>
###xml 403 410 <span type="species:ncbi:1392">anthrax</span>
###xml 473 485 <span type="species:ncbi:1392">B. anthracis</span>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
###xml 661 673 <span type="species:ncbi:1392">B. anthracis</span>
###xml 929 941 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1089 1101 <span type="species:ncbi:1392">B. anthracis</span>
Pulmonary anthrax is an acute disease of animals and humans caused by inhalation of spores of pathogenic strains of B. anthracis[1]-[3]. Upon infection, the spore germinates and begins to outgrow into toxin-producing replicating bacilli, which can ultimately kill the infected host [2],[11],[12]. LT, a major virulence factor of B. anthracis, has been shown to play a key role in the pathophysiology of anthrax and associated mortality [11],[12]. We demonstrated here that B. anthracis represses the mouse pulmonary inflammatory response (PMN recruitment and cytokine production) and that LT plays a key role in this inhibition. Moreover, in the absence of LT, B. anthracis induces this response, which suggests that component(s) of this bacterium is (are) able to induce an inflammatory reaction, and that their action is masked by the inhibitory effect of LT. This is consistent with previous studies, which have reported that B. anthracis spores stimulate cytokine production in various cells [16]-[18]. Our recent study showed that peptidoglycan, a constitutive cell wall component of B. anthracis, induces type-IIA secreted phospholipase A2 expression in AMs through a NF-kappaB dependent process [13]. In the earlier stages of infection, inhaled spores trigger an inflammatory response that is subsequently repressed as soon as LT is produced by outgrowing bacilli. Therefore, it was of a great interest to identify the molecular mechanisms by which LT represses the expression of genes involved in the inflammatory response.
###end p 39
###begin p 40
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Strahl1">[7]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Volmat1">[10]</xref>
###xml 164 176 164 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Baldari1">[11]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Fukao1">[12]</xref>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Brownell1">[19]</xref>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Soloaga1">[22]</xref>
###xml 1147 1151 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Soloaga1">[22]</xref>
###xml 1152 1156 1152 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Clayton2">[23]</xref>
###xml 1481 1485 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Soloaga1">[22]</xref>
###xml 1486 1490 1486 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Clayton2">[23]</xref>
###xml 164 176 <span type="species:ncbi:1392">B. anthracis</span>
Early studies demonstrated that phosphorylation of histones at specific amino acid residues regulates gene transcription [7]-[10]. The present study suggested that B. anthracis targets chromatin access for transcription factors, which may alter gene transcription. LT has been shown to suppress cytokine production by a process involving the disruption of MAPKKs [11],[12], yet the molecular mechanisms by which this disruption inhibits the expression of inflammatory genes remained to be elucidated. We reported here for the first time that inhibition of cytokine production in epithelial cells by LT occurs via a process involving an alteration of histone H3 phosphorylation/acetylation. Histone modification such as phosphorylation of H3 and acetylation of lysine on histones H3 or H4 can be associated with transcriptional activation [19]-[22]. Indeed, gene expression occurs when the chromatin is in the opened conformation that is promoted in part by histone phosphorylation. Moreover, phosphorylation of H3 is mediated, in part, by mitogen and stress-activated kinase (MSK), which is activated by MAPK (p38-MAPK and ERK) signaling pathways [22],[23]. Our findings showed that LT blocked the activation of p38-MAPK and ERK (as a consequence of MAPKK cleavage by LT) and that this inhibition led to the alteration of histone H3 phosphorylation through a process involving an inhibition of MSK2 phosphorylation. Indeed, MSK2 has been shown to mediate histone H3 phophorylation [22],[23].
###end p 40
###begin p 41
###xml 271 274 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Hoffmann1">[6]</xref>
###xml 347 350 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1224 1227 1204 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1329 1334 1309 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1334 1338 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Arbibe1">[24]</xref>
###xml 1380 1397 1360 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shigella flexneri</italic>
###xml 1583 1594 1559 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. flexneri</italic>
###xml 1599 1611 1575 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1723 1734 1699 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. flexneri</italic>
###xml 1848 1860 1824 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 2136 2140 2112 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Batty1">[25]</xref>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
###xml 1380 1397 <span type="species:ncbi:623">Shigella flexneri</span>
###xml 1583 1594 <span type="species:ncbi:623">S. flexneri</span>
###xml 1599 1611 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1723 1734 <span type="species:ncbi:623">S. flexneri</span>
###xml 1848 1860 <span type="species:ncbi:1392">B. anthracis</span>
The present study shows that both MAPK and NF-kappaB pathways are essential for IL-8 expression in Beas-2B cells. These results are consistent with previous reports showing that these pathways play a major role in the induction of IL-8 expression in various cell systems [6]. Our results showed that NF-kappaB activation in Beas-2B cells occurred via a MAPK-independent process. This led us to suggest that MAPK act down-stream of NF-kappaB activation to modulate IL-8 expression. Our results suggested that epigenetic remodeling initiated by MAPK-induced H3 phosphorylation promotes the accessibility of IL-8 promoters to NF-kappaB, thereby enhancing IL-8 expression. This process seems also to play a role in the modulation of KC promoter activity, the mouse functional orthologue of human IL-8 promoter. This epigenetic modulation, which is in part under the control of MAPKs, may occur only in the chromatin context whose remodeling favors the recruitment of transcription machinery components including NF-kappaB. This may explain why MAPK inhibition failed to interfere with the activation of the transfected IL-8 promoter reporter construct, which is not in the context of chromatin and therefore cannot be modulated via a MAPK-dependent epigenetic remodeling. Our results are in agreement with the recent study of Arbibe et al[24] showing that OspF, a virulence factor of Shigella flexneri endowed with phosphatase activity, reduced H3 phosphorylation on a limited subset of gene promoters, including IL-8 promoter, which then become inaccessible to NF-kappaB. Although both S. flexneri and B. anthracis downregulate inflammatory gene expression, they clearly interfere with H3 phosphorylation at different levels: S. flexneri acts downstream H3 phosphorylation by dephosphorylating ERK p38-MAPKs once they translocate into nucleus whereas B. anthracis blocks this process upstream these MAPKs by a cleavage of MAPKKs in the cytosol. However, it should be noted that, in addition to its epigenetic effect on the transcriptional activity of the IL-8 promoter, LT can also inhibit IL-8 expression via destabilization of IL-8 mRNA [25].
###end p 41
###begin p 42
###xml 67 79 67 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 175 187 175 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 240 248 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Russell1">[26]</xref>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Russell2">[27]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Russell1">[26]</xref>
###xml 452 464 452 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Lincoln1">[2]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Ross1">[3]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Glomski1">[28]</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Loving1">[31]</xref>
###xml 903 910 903 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1356 1360 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Chakrabarty2">[32]</xref>
###xml 1377 1381 1377 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Bonuccelli1">[33]</xref>
###xml 1458 1470 1458 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1546 1558 1546 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 1689 1693 1689 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Cario1">[34]</xref>
###xml 1707 1711 1707 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Schmeck1">[35]</xref>
###xml 1956 1968 1956 1968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthtacis</italic>
###xml 2128 2140 2128 2140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 2140 2144 2140 2144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Cote1">[36]</xref>
###xml 67 79 <span type="species:ncbi:1392">B. anthracis</span>
###xml 158 165 <span type="species:ncbi:1392">anthrax</span>
###xml 175 187 <span type="species:ncbi:1392">B. anthracis</span>
###xml 452 464 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1458 1470 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1546 1558 <span type="species:ncbi:1392">B. anthracis</span>
###xml 2052 2059 <span type="species:ncbi:1392">anthrax</span>
###xml 2079 2083 <span type="species:ncbi:10090">mice</span>
###xml 2128 2140 <span type="species:ncbi:1392">B. anthracis</span>
###xml 2258 2265 <span type="species:ncbi:1392">anthrax</span>
Recent studies have shown that lung epithelial cells interact with B. anthracis suggesting that these cells may play a role in host defense against pulmonary anthrax. Indeed, B. anthracis spores are taken up by lung epithelial cells either in vitro[26] and in vivo[27] and this uptake is followed by entry and germination of spores, though with low efficiency [26]. AMs and dendritic cells are also known to participate in host defense against inhaled B. anthracis, and play a role in spore uptake and germination [2],[3]. Interestingly, recent reports showed that spore germination and bacterial growth occurred at the site of entry, i.e. nasopharynx and alveoli [28]-[31]. Thus, available data suggest that spore germination, initial bacterial multiplication and lung epithelium crossing may occur along the respiratory tract. The respective role of each cell population still remains to be evaluated in vivo, in particular whether efficiency in spore uptake is paralleled with efficient dissemination from the lung. On the other hand, inhibition by toxins of the inflammatory response initiated by lung epithelial cells may favor the implication of AMs and dendritic cells in subsequent dissemination at later stages of the disease. Moreover, induction of cytokine production by epithelial cells has been shown to occur through a MAPK-dependent pathway [32]. Another report [33] showed that bronchial epithelial cells highly expressed TEM8, a receptor of B. anthracis toxins, thus confirming the implication of these cells in host response to B. anthracis. Lung epithelial cells have been shown to contribute to the innate immune response after interaction with pathogens such as virus [34] and bacteria [35]. Given the role of lung epithelial cells as an important source of chemokines (including IL-8), the inhibition of their activation by LT may have a critical impact on PMN recruitment, and therefore would compromise host defense against inhaled B. anthtacis. Indeed, a previous study showed that PMN play a role in host defense in pulmonary anthrax since PMN-depleted mice exhibited higher mortality by inhalation of B. anthracis[36]. Although lung epithelial cells could play a role during the activation of immune response in the early steps of anthrax infection, it should be, however, kept in mind that other pulmonary cell types such AMs, whose cytokine production is repressed by LT (our unpublished data), may contribute to the inhibitory effect of LT on lung IL-8/KC production.
###end p 42
###begin p 43
###xml 35 47 35 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 35 47 <span type="species:ncbi:1392">B. anthracis</span>
###xml 611 618 <span type="species:ncbi:1392">anthrax</span>
In conclusion, we report here that B. anthracis represses the expression of cytokines such as IL-8 in epithelial cells. This inhibition occurs through a process involving LT-mediated epigenetic reprogramming, and might represent a novel mechanism by which this bacterium can evade the host innate immune response. This reprogramming would take place following spore germination and may compromise pulmonary host defense leading to bacterial proliferation and ultimate host death. Therefore, the use of pharmacological approaches to inhibit LT may represent a potential therapeutic strategy for the treatment of anthrax.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Animals and reagents
###end title 45
###begin p 46
###xml 243 248 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grade</italic>
###xml 269 276 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1417 1429 1395 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 117 121 <span type="species:ncbi:9925">goat</span>
###xml 127 133 <span type="species:ncbi:9986">rabbit</span>
###xml 197 201 <span type="species:ncbi:9913">calf</span>
###xml 269 276 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 343 348 <span type="species:ncbi:9606">Human</span>
###xml 1274 1279 <span type="species:ncbi:9606">human</span>
###xml 1284 1289 <span type="species:ncbi:10090">mouse</span>
###xml 1417 1429 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1477 1482 <span type="species:ncbi:9606">Human</span>
###xml 1583 1588 <span type="species:ncbi:10090">Mouse</span>
###xml 1672 1680 <span type="species:ncbi:9606">Children</span>
###xml 1746 1750 <span type="species:ncbi:10090">mice</span>
###xml 1832 1836 <span type="species:ncbi:10090">Mice</span>
F-12K nutrient mixture, antibiotics, glutamine, Hanks' Balanced Salt Solution, Alexa Fluor(R) 488 F(ab') fragment of goat anti-rabbit IgG (H+L) were from Invitrogen (Cergy-Pontoise, France). Fetal calf serum was from PAA (Etobicoke, USA). (TLRgradetrade mark) LPS from E. coli (Serotype 0111:B4) was from Alexis Biochemicals (San Diego, USA). Human beta-actin antibody was from Sigma Aldrich (St. Louis, USA). SB203580 was from Tebu-bio (Le Perray, France). Antibodies against histone H2B (ab1790), histone H3 (ab1791), acetyl-histone H3 (H3AcK9, ab4441), methyl-histone H3 (H3me3K4, ab8580) and (H3me3K9, ab8898) and MSK-2 (ab42101) were from Abcam (Cambridge, USA). Antibodies against phospho-histone H3 (H3pS10, 05-817) and phospho-acetyl-histone H3 (H3pS10-AcK14, 07-353) were from Upstate Cell Signaling (New York, USA). Antibodies against RNA Polymerase II (RNAPII, sc-899), MEK-1 (sc-219), MEK-3 (sc-959) and the p65 subunit of NF-kappaB (sc-372) were from Santa-Cruz (Santa-Cruz, USA). Antibodies against MEK-2 (9125), p38-MAPK (9212), phospho-p38-MAPK (p38pT180-Y182, 9211), ERK (9102), phospho-ERK (ERKpT202-Y204, 9101), JNK (9252) and phospho-JNK (JNKpT183-Y185, 4668) and PD98059 were from Cell Signaling (Danvers, USA). Antibody against phospho-MSK-2 (Ser196), human and mouse recombinant TNFalpha were from R&D systems (Minneapolis, USA). Recombinant Lethal Factor (LF) and Protective Antigen (PA) from B. anthracis were from List Biological lab (Campbell, USA). Human bronchial epithelial cell line Beas-2B was from the American Type Cell Collection (Rockville, USA). Mouse alveolar epithelial cell line MLE-15 was a gift from Dr. J.A. Whitsett (Cincinnati Children's Hospital Medical Center, Cincinnati, USA). 7 weeks old C57/BL6 mice were supplied by the Centre d'Elevage R. Janvier (Le Genest Saint-Isle, France). Mice were cared for in accordance with Pasteur Institute guidelines, in compliance with the European Animal Welfare regulations.
###end p 46
###begin title 47
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 0 12 <span type="species:ncbi:1392">B. anthracis</span>
B. anthracis strains
###end title 47
###begin p 48
###xml 38 50 38 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. anthracis</italic>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Pezard1">[37]</xref>
###xml 38 50 <span type="species:ncbi:1392">B. anthracis</span>
The following isogenic non-capsulated B. anthracis strains were studied: the single mutant RP9 that produces active LF and inactive EF, and the double-mutant RPLC2 producing inactive LF and inactive EF. Both mutants produce functional PA [37].
###end p 48
###begin title 49
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse treatments
###end title 49
###begin p 50
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Balloy1">[38]</xref>
###xml 162 163 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 475 479 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Glomski1">[28]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
Mice were anesthetized by i.p. injection of a mixture of ketamine-xylazine as previously described [38] before intranasal instillation of 50 microl of bacilli (107 cfu) or LPS (330 microg/kg). In certain experiments, anesthetized mice received intratracheal instillation of 10 microl of LT (550 microg/kg = 550 microg PA+550 microg LF, per Kg) 1 h before instillation of LPS or bacilli. Nascent bacilli were recovered from a 90 min growth in R medium as previously described [28].
###end p 50
###begin title 51
Incubation of cells with bacteria, toxins, and drugs
###end title 51
###begin p 52
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Dobbs1">[39]</xref>
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Corti1">[40]</xref>
Epithelial cells isolated from lung homogenates as previously described [39],[40], Beas-2B and MLE-15 cell lines were pretreated with LT (PA+LF), PD98059, SB203580, or BAY for 1 h before incubation with LPS or TNFalpha at the concentrations and durations indicated in the figure legends. In other experiments, 1 h after addition of drugs or LT, Beas-2B cells were infected with bacilli for 3 h in the absence of antibiotics, washed and re-incubated for additional 24 h in a medium supplemented with antibiotics.
###end p 52
###begin title 53
Cytokine enzyme immunoassays and PMN counts
###end title 53
###begin p 54
IL-8, KC, IL-6 and MIP-1 concentrations were measured in culture medium or in BALs using DuoSet ELISA kits from R&D systems (Minneapolis, USA). Total cell counts in BALs were determined with a Coulter Counter from Coulter Electronics (Margency, France), and differential cell counts were determined after cytospin centrifugation and staining with Diff-Quick products.
###end p 54
###begin title 55
Protein extraction and Western blot analyses
###end title 55
###begin p 56
Proteins were extracted from Beas-2B cells using RIPA and then 20 microg of total proteins were subjected to SDS-PAGE. Proteins were transferred to membrane from Millipore (Billerica, USA), which were blocked and probed for 1 h with the indicated antibodies. After washing, the immunoreactive bands were visualized with a specific peroxidase-conjugated anti-immunoglobulin G (IgG) antibody and using an ECL Plus Western Blotting Detecting System (Amersham, Biosciences).
###end p 56
###begin title 57
Nuclear protein extraction and Electrophoretic Mobility Shift Assays
###end title 57
###begin p 58
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000359-Feuillard1">[41]</xref>
###xml 156 191 152 187 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGT TGA GGG GAC TTTT CCC AGG C-3</named-content>
###xml 198 200 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Nuclear proteins were extracted from Beas-2B cells, as previously described [41]. The NF-kappaB double-stranded oligonucleotides (Santa Cruz Biotechnology) 5'-AGT TGA GGG GAC TTTT CCC AGG C-3 gamma-32P-labeled with T4 polynucleotide kinase (Biolabs) were incubated for 20 min at room temperature, with 5 microg of nuclear extract, 10 microl of binding buffer (40 mM HEPES (pH 7), 140 mM KCl, 4 mM DTT, 0.02% Nonidet P-40, 8% Ficoll, 200 microg/ml BSA, 1 microg of poly(dI:dC). Migration was performed on a 5% polyacrylamide gel in 0.5% Tris/borate/EDTA buffer at 150 V for 2 h. Gels were dried and exposed for 2 to 12 h.
###end p 58
###begin title 59
Immunofluorescence analysis
###end title 59
###begin p 60
Beas-2B cells were fixed for 10 min with 3.7% (weight/volume) paraformaldehyde in PBS and then were permeabilized with 0.5% (volume/volume) Triton-X 100 in PBS. Fixed cells were treated 1 h with the indicated primary antibodies.
###end p 60
###begin title 61
Transfection studies
###end title 61
###begin p 62
Beas-2B cells were cultured in 24 well plates, at 70% confluence and transfected with an IL-8 promoter construct [133]-Luc, an [Delta NF-kappaB] IL-8 promoter construct mutated on NF-kappaB site or a NF-kappaB construct-Luc. After indicated treatment, luciferase activity was measured using a luciferase reporter assay kit, with signal detection for 12 s by a luminometer (Berthold, Pforzheim, Germany),
###end p 62
###begin title 63
RNA extraction and real time Reverse-Transcription PCR analysis
###end title 63
###begin p 64
###xml 904 933 868 897 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTGTGATGACTCAGGTTTGCCCT-3</named-content>
###xml 946 976 910 940 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGCTTGTGTGCTCTGCTGTCTCT-3&#8242;</named-content>
###xml 1022 1048 986 1012 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TCCCATCACCATCTTCCAGG-3&#8242;</named-content>
###xml 1059 1085 1023 1049 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATCGCCCCACTTGATTTTG-3&#8242;</named-content>
###xml 1125 1154 1089 1118 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGCTCTGGAGTTTCGAGCATAA-3</named-content>
###xml 1167 1197 1131 1161 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTCTGGAGTGCTGGAACTGGTTA-3&#8242;</named-content>
###xml 1214 1244 1178 1208 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCAAGCAGCCTCTCCCAGATCAA-3&#8242;</named-content>
###xml 1256 1286 1220 1250 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATTTGCCAGTCCTTTGTGGCTGA-3&#8242;</named-content>
###xml 1304 1330 1268 1294 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCCGCTTTGCAGGTGTATT-3&#8242;</named-content>
###xml 1342 1370 1306 1334 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCAAGGTGCTATTGAAAGCCT-3&#8242;</named-content>
###xml 1388 1418 1352 1382 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTGAATGTAACCTGCCGCTACGC-3&#8242;</named-content>
###xml 1430 1460 1394 1424 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGTACTGTTGAAAGCCTGGCAGA-3&#8242;</named-content>
###xml 494 500 <span type="species:ncbi:10090">murine</span>
Total RNA was extracted using an RNeasy kit from Qiagen (Courtaboeuf, France). DNase treatment was performed using 2 microg of extracted RNA, 1 microl of DNase I (Amersham Biosciences, Orsay, France), and 0.5 microl of RNasin (Promega, Madison, WI) in a total volume of 20 microl in the manufacturer's buffer. cDNA were obtained by incubating RNA with 1 mM dNTP (Eurobio, Les Ulis, France), 1.5 microl of hexamers as primers, 20 units of RNasin (Promega, Madison, WI), and 300 units of Moloney murine leukaemia virus reverse transcriptase RNase H minus (Promega, Madison, WI) in a total volume of 50 microl of the manufacturer's buffer for 1 h at 42degreesC and 10 min at 70degreesC. Real-time PCR was performed using the SYBR Green kit (Stratagene Brilliant II) and analyzed using the MxPro software (Stratagene, La Jolla, CA). The following primers were used. Proximal promoter of IL-8 (ppIL-8): sense 5'-AGTGTGATGACTCAGGTTTGCCCT-3; anti-sense 5'-AAGCTTGTGTGCTCTGCTGTCTCT-3'; proximal promoter of GAPDH (ppGAPDH): sense 5' TCCCATCACCATCTTCCAGG-3', antisens 5'-CATCGCCCCACTTGATTTTG-3'. Proximal promoter of KC (ppKC): sense 5'-GGAGCTCTGGAGTTTCGAGCATAA-3; anti-sense 5'-AGTCTGGAGTGCTGGAACTGGTTA-3'; KC-7 kb: sense 5'-TTCAAGCAGCCTCTCCCAGATCAA-3', antisense 5'-CATTTGCCAGTCCTTTGTGGCTGA-3'. hCD44ex2: sense 5'-TGCCGCTTTGCAGGTGTATT-3', antisense 5'-GGCAAGGTGCTATTGAAAGCCT-3', mCD44ex2: sense 5'-TTTGAATGTAACCTGCCGCTACGC-3', antisense 5'-AGGTACTGTTGAAAGCCTGGCAGA-3'. The PCR conditions were: 95degreesC 10 min, and 45 cycles at 94degreesC 15'' 60degreesC 30'' 72degreesC 20'', followed by the dissociation curve program for the analysis of the PCR products.
###end p 64
###begin title 65
Chromatin immunoprecipitation (ChIP)
###end title 65
###begin p 66
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Formaldehyde-fixed human Beas-2B and mouse MLE-15 cells were extracted to remove unfixed components. The average size of sonicated chromatin was approximately 500 base pairs, allowing analysis of the PCR products (150 base pairs; data not shown). Sonicated chromatin corresponding to 5.106 cells was immunoprecipitated with 8 microg of irrelevant IgG or specific antibodies as indicated in corresponding figures. After extensive washing and reversed crosslinking, nucleic acids were used for quantitative real-time PCR, done with SYBR Green kits as detailed above.
###end p 66
###begin title 67
Control of cell viability
###end title 67
###begin p 68
Cell viability was checked by the trypan blue dye exclusion test. Cell lysis was controlled measuring the release of lactate dehydrogenase (LDH) activity using a commercial kit from Boehringer (Mannheim, Germany).
###end p 68
###begin title 69
Statistical analysis
###end title 69
###begin p 70
Data are expressed as the means+/-S.E.M. and statistical analyses were performed using an unpaired Student's t test or an ANOVA test. Statistical significances are indicated as * P<0.05; ** p<0.01; *** p<0.001.
###end p 70
###begin p 71
IL-8 promoter constructs was a gift from Dr. Naofumi Mukaida (Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Japan). We warmly thank Dr. Michel Chignard and Jean-Michel Sallenave for their comments and criticisms.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax.
###end article-title 73
###begin article-title 74
###xml 46 53 <span type="species:ncbi:1392">anthrax</span>
Role of the lymphatics in the pathogenesis of anthrax.
###end article-title 74
###begin article-title 75
###xml 20 27 <span type="species:ncbi:1392">anthrax</span>
The pathogenesis of anthrax following the administration of spores by the respiratory route.
###end article-title 75
###begin article-title 76
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax vaccines: past, present and future.
###end article-title 76
###begin article-title 77
Interleukin-8, a chemotactic and inflammatory cytokine.
###end article-title 77
###begin article-title 78
Multiple control of interleukin-8 gene expression.
###end article-title 78
###begin article-title 79
The language of covalent histone modifications.
###end article-title 79
###begin article-title 80
The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase.
###end article-title 80
###begin article-title 81
Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation.
###end article-title 81
###begin article-title 82
The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases.
###end article-title 82
###begin article-title 83
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax toxins: A paradigm of bacterial immune suppression.
###end article-title 83
###begin article-title 84
###xml 27 34 <span type="species:ncbi:1392">anthrax</span>
Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.
###end article-title 84
###begin article-title 85
Edema Toxin impairs Anthracidal Phospholipase A2 Expression by Alveolar Macrophages.
###end article-title 85
###begin article-title 86
###xml 49 56 <span type="species:ncbi:1392">anthrax</span>
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
###end article-title 86
###begin article-title 87
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
###end article-title 87
###begin article-title 88
###xml 36 54 36 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 36 54 <span type="species:ncbi:1392">Bacillus anthracis</span>
Cytokine response to infection with Bacillus anthracis spores.
###end article-title 88
###begin article-title 89
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 0 18 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways.
###end article-title 89
###begin article-title 90
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax edema toxin cooperates with lethal toxin to impair cytokine production during infection of dendritic cells.
###end article-title 90
###begin article-title 91
###xml 54 59 <span type="species:ncbi:4932">yeast</span>
Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation.
###end article-title 91
###begin article-title 92
Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors.
###end article-title 92
###begin article-title 93
p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment.
###end article-title 93
###begin article-title 94
MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14.
###end article-title 94
###begin article-title 95
MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation.
###end article-title 95
###begin article-title 96
An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses.
###end article-title 96
###begin article-title 97
###xml 60 78 60 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 60 78 <span type="species:ncbi:1392">Bacillus anthracis</span>
Inhibition of mitogen-activated protein kinase signaling by Bacillus anthracis lethal causes destabilization of interleukin-8 mRNA.
###end article-title 97
###begin article-title 98
###xml 27 45 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells.
###end article-title 98
###begin article-title 99
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 58 76 <span type="species:ncbi:1392">Bacillus anthracis</span>
In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells.
###end article-title 99
###begin article-title 100
###xml 80 87 <span type="species:ncbi:1392">anthrax</span>
Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.
###end article-title 100
###begin article-title 101
###xml 23 41 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting.
###end article-title 101
###begin article-title 102
###xml 13 31 <span type="species:ncbi:1392">Bacillus anthracis</span>
Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging.
###end article-title 102
###begin article-title 103
###xml 8 15 <span type="species:ncbi:1392">anthrax</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
###end article-title 103
###begin article-title 104
###xml 37 55 37 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 37 55 <span type="species:ncbi:1392">Bacillus anthracis</span>
Human lung innate immune response to Bacillus anthracis spore infection.
###end article-title 104
###begin article-title 105
###xml 56 74 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 135 142 <span type="species:ncbi:1392">anthrax</span>
ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection.
###end article-title 105
###begin article-title 106
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.
###end article-title 106
###begin article-title 107
###xml 0 22 <span type="species:ncbi:446">Legionella pneumophila</span>
Legionella pneumophila-induced NF-kappaB- and MAPK-dependent cytokine release by lung epithelial cells.
###end article-title 107
###begin article-title 108
###xml 67 85 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.
###end article-title 108
###begin article-title 109
###xml 60 78 <span type="species:ncbi:1392">Bacillus anthracis</span>
Contribution of individual toxin components to virulence of Bacillus anthracis.
###end article-title 109
###begin article-title 110
Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.
###end article-title 110
###begin article-title 111
Isolation and culture of alveolar type II cells.
###end article-title 111
###begin article-title 112
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Isolation and primary culture of murine alveolar type II cells.
###end article-title 112
###begin article-title 113
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-kappaB/Rel complexes.
###end article-title 113
###begin p 114
The authors have declared that no competing interests exist.
###end p 114
###begin p 115
BR was supported by the Fondation pour la Recherche Medicale (Bourse Marianne Josso). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 115

